Celmatix

Celmatix

生物技术研究

New York,NY 6,334 位关注者

A preclinical-stage women’s health biotech focused uniquely on ovarian biology.

关于我们

Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. Celmatix’s proprietary multi-omic ovarian health platform, the world’s largest of its kind, is the foundation of the company’s novel pipeline of first-in-class therapies. For more information visit www.celmatix.com.

网站
https://www.celmatix.com
所属行业
生物技术研究
规模
11-50 人
总部
New York,NY
类型
私人持股
创立
2009
领域
Reproductive Biology and Medicine、Genomics、Bioinformatics、Biotech、Women's health和Drug Development

地点

Celmatix员工

动态

相似主页

查看职位

融资

Celmatix 共 10 轮

上一轮

未知

US$6,500,000.00

Crunchbase 上查看更多信息